AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

RADIOPHARM THERANOSTICS LTD

0.010

0.000

Volume:4.96M

Turnover:50.25K

Market Cap:43.38M

PE:-0.53

High:0.011

Open:0.010

Low:0.010

Close:0.010

52wk High:0.040

52wk Low:0.009

Shares:4.34B

Float Shares:3.34B

Volume Ratio:0.20

T/O Rate:0.15%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.019

EPS(LYR):-0.018

ROE:-92.10%

ROA:-28.33%

PB:0.84

PE(LYR):-0.54

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Radiopharm Theranostics Advances 177Lu-Rad202 Phase 1 HEAT Trial to 180 mCi Dose Cohort After DSMC Review

Radiopharm Theranostics - Rad202 Study Shows Clinical Proof-of-Concept with Positive Safety and Biodistribution

THOMSON REUTERS

Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-Rad202 Phase 1 Heat Clinical Trial

THOMSON REUTERS

Radiopharm Theranostics - Advances Rad202 Phase 1 Trial to 180Mci Dose in Her2-Positive Advanced Solid Tumors

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/RAD.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RAD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RAD.AU\",,,,,undefined,":{"symbol":"RAD.AU","market":"AU","secType":"STK","nameCN":"RADIOPHARM THERANOSTICS LTD","latestPrice":0.01,"timestamp":1787292720000,"preClose":0.01,"halted":0,"volume":4959375,"delay":0,"changeRate":0,"nameEN":"RADIOPHARM THERANOSTICS LTD","floatShares":3342779849,"shares":4337549000,"eps":-0.019034,"marketStatus":"Market Closed","change":0,"latestTime":"08-21 16:12:00 AEST","open":0.01,"high":0.011,"low":0.01,"amount":50250,"amplitude":0.1,"askPrice":0.011,"askSize":1836974,"bidPrice":0.01,"bidSize":14762,"shortable":3,"etf":0,"ttmEps":-0.019034,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.01,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0.19748640911225376,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"RAD.AU","preClose":0.01,"auctionPrice":0.01,"auctionVolume":178500,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292595380}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RAD.AU\",,,,,undefined,":{"symbol":"RAD.AU","floatShares":3342779849,"roa":"-28.33%","roe":"-92.10%","lyrEps":-0.018424,"volumeRatio":0.19748640911225376,"shares":4337549000,"dividePrice":0,"high":0.011,"amplitude":0.1,"preClose":0.01,"low":0.01,"week52Low":0.009,"pbRate":"0.84","psRate":"2.66","week52High":0.04,"institutionHeld":0,"latestPrice":0.01,"committee":-0.984056,"eps":-0.019034,"divideRate":0,"volume":4959375,"delay":0,"ttmEps":-0.019034,"open":0.01,"prevYearClose":0.025,"prevWeekClose":0.011,"prevMonthClose":0.014,"prevQuarterClose":0.019,"fiveDayClose":0.011,"twentyDayClose":0.019,"sixtyDayClose":0.021,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RAD.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RAD.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RAD.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660286639","title":"Radiopharm Theranostics Advances 177Lu-Rad202 Phase 1 HEAT Trial to 180 mCi Dose Cohort After DSMC Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2660286639","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660286639?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:03","pubTimestamp":1787223813,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics advances 177Lu-RAD202 Phase 1 HEAT trial to 180 mCi dose cohort after DSMC reviewRadiopharm Theranostics moved its Phase 1 HEAT trial of 177Lu-RAD202 into Cohort 4 following a ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL8L5MBh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","RAD.AU","IE00B64PRP62.GBP","IE00BN0W2W23.USD","BK4112","BK7067","IE00BQXX3C00.GBP","NDAQ","LU2095319765.USD","IE00BQXX3F31.USD","LU0314104364.USD","IE00BN0W2V16.EUR","SG9999014005.SGD","BK4585","SG9999014013.SGD","IE00BQXX3D17.EUR","LU2210149790.SGD","BK4588","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","IE00BGHQF748.EUR","SG9999014021.USD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660728687","title":"Radiopharm Theranostics - Rad202 Study Shows Clinical Proof-of-Concept with Positive Safety and Biodistribution","url":"https://stock-news.laohu8.com/highlight/detail?id=2660728687","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660728687?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:00","pubTimestamp":1787223601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nTUABR8NCB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","RAD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660332286","title":"Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-Rad202 Phase 1 Heat Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2660332286","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660332286?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:00","pubTimestamp":1787223601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nTUABR8NCB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","RAD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660286382","title":"Radiopharm Theranostics - Advances Rad202 Phase 1 Trial to 180Mci Dose in Her2-Positive Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660286382","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660286382?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:00","pubTimestamp":1787223601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nTUABR8NCB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RAD.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":17,"pageCount":1,"totalSize":66,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RAD.AU\",params:#limit:6,delay:true,,,undefined,":[]}}